Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tom van de Berg"'
Autor:
Yvonne M. C. Henskens, Jan-Willem E M Sels, Bas C. T. van Bussel, Magdolna Nagy, Tom Van De Berg, Rene van Oerle, Henri M. H. Spronk, Hugo ten Cate, Anne-Marije Hulshof
Publikováno v:
Thrombosis Research, 201, 84-89. Elsevier Science
Thrombosis Research
Thrombosis Research
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection is associated with a clear prothrombotic phenotype. Although the exact pathophysiological mechanisms are not yet fully understood, thrombosis is clearly a highly impo
Autor:
Floor C.J.I. Moenen, Tom van de Berg, Arian van der Veer, Rene Van Oerle, Dave Hellenbrand, Henri M.H. Spronk, Erik A.M. Beckers, Yvonne M.C. Henskens
Publikováno v:
Blood. 140:11292-11293
Autor:
Joyce van Beers, Alice M. Todaro, Tom Van De Berg, Floor C. J. I. Heubel-Moenen, Elisabetta Castoldi, Yvonne M. C. Henskens, Erik A M Beckers, Kanin Wichapong
Publikováno v:
Blood. 138:1032-1032
Background Von Willebrand Factor (VWF) is a multimeric protein largely involved in both primary and secondary hemostasis. The diagnosis and classification of von Willebrand Disease (VWD) patients can be challenging. In this poster we explore the gene
Publikováno v:
Blood. 138:4232-4232
Background: Hemophilia A (HA) is a bleeding disorder characterized by decreased or absent FVIII. Clinical analysis of coagulation potential in this patient population is classically based on APTT based FVIII assays. Although both the one-stage FVIII
Autor:
Rene van Oerle, Tilman M. Hackeng, Rafael Apitz, H. Coenraad Hemker, Tom Van De Berg, M.G.L. Christella D. Thomassen, Henri M. H. Spronk, Dennis Suylen
Publikováno v:
Blood. 134:1146-1146
Background: Thrombin generation and other clotting assays suffer from a wide variation of pre-analytical variables. One of those pre-analytical variables is contact activation through blood withdrawal methods, different syringes, differences in blood